Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Nakamatsu, M. Allen, T. Weimkem, B. Moffett, M. Zervos, J. A. Ramirez (Louisville, KY, Detroit, MI, United States Of America). Vancomycin MICs for respiratory isolates of community-associated MRSA and hospital-associated MRSA. Eur Respir J 2007; 30: Suppl. 51, 2575

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007 Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Antibiotic susceptibility patterns of respiratory strains of Staphylococcus aureus in a Turkish university hospital Source: Eur Respir J 2003; 22: Suppl. 45, 148s Year: 2003 Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Significance of methicillin-resistant staphylococcus aureus in lower respiratory tract infections Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial Source: Eur Respir J 2004; 23: 921-926 Year: 2004 Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 MRSA as a cause of community-acquired pneumonia Source: Eur Respir J 2009; 34: 1013-1014 Year: 2009 Methicillin-resistant Staphylococcus aureus (MRSA) active screening in a Pulmonology department. Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Emergence of penicillin resistant Streptococcus pneumoniae in Pakistan Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005 Community-acquired pneumonia due to S. aureus Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011